NL-OMON48488招募中不适用
Effect of androgen deprivation therapy on uptake of PSMA ligand in patients with salivary duct carcinoma: an explorative study. - ADT-SCA
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients must have the ability to provide written informed consent.
- •Patients must be >= 18 years of age.
- •Patients must have histological, pathological, and/or cytological
- •confirmation of salivary duct carcinoma, androgen receptor positive.
- •Only patients with locally advanced, recurrent or metastatic salivary duct
- •carcinoma can participate.
- •Patients must have at least one lesion with a diameter of >= 1.5 cm.
- •Patients whom intend to start androgen deprivation therapy, after this has
- •been re-commended by the treating physician as standard treatment.
排除标准
- •Contra-indication for PET imaging: pregnancy or breast feeding or severe
- •claustrophobia
- •Impaired renal function: MDRD <30 ml/min/1,73 m2
- •Impaired liver function: AST and ALT ALT >= 2.5 x ULN (>=5 x ULN for patients
- •with liver metastases)
研究者
相似试验
进行中（未招募）
1 期
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigeMedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10071119 Term: Hormone-dependent prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Metastatic prostate cancerEUCTR2018-004853-26-FITurku University Hospital35
进行中（未招募）
1 期
The effect of androgen deprivation therapy on prostate specific membrane antigen (PSMA)Prostate cancerEUCTR2017-002345-29-FITurku University Hospital5
招募中
不适用
To determine whether androgen deprivation therapy or androgen blockage therapy upregulates receptor activity of Gallium68 Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) scans for men with castrate resistant prostate cancer.Metastatic Prostate CancerACTRN12617001116314St Vincent's Hospital, Sydney20
尚未招募
3 期
Effect of systematic lifestyle advice & use of cholesterol reducing drugs on cardiovascular disease outcomes among men with newly diagnosed prostate cancer on androgen deprivation therapy.CTRI/2023/07/054807Dr Jehonathan Pinthus Dr Leong Darryl
进行中（未招募）
4 期
The effect of intermittent versus continuous androgen deprivation therapy in Chinese patients with advanced prostate cancer: A prospective controlled Trial from ChinaCancer - Prostateprostate cancerACTRN12613000107729Changhai Hospital, Second Military Medical University100